MEETINGS - BIC (Germany) May 2008
This article was originally published in Clinica
Executive Summary
Business in China, a "procurement summit" for European companies wishing to establish or expand their operations in China, will take place during May 28-29 2008 at the Berliner Congress Centre, Berlin, Germany. Among the industries included are medical technology, biotechnology and pharmaceuticals. Delegate numbers are restricted to 800 to ensure that bespoke agendas can be created and addressed for each attendee, says BIC. A conference will run concurrently to provide key aspects of conducting business in China and to highlight the business prospects of some of China's regions. For more information and to register, see: www.businesschinaexpo.com
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.